Alimera Sciences Financials

Alimera Sciences Stock Summary

Alimera Sciences competes with Shuttle Pharmaceuticals, Lifecore Biomedical, Journey Medical, Organogenesis Holdings, and Cyclo Therapeutics. Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 145 people.

Alimera Sciences Key Financial Ratios

Alimera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alimera Sciences's current stock value. Our valuation model uses many indicators to compare Alimera Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alimera Sciences competition to find correlations between indicators driving Alimera Sciences's intrinsic value. More Info.Alimera Sciences is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Alimera Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Alimera Sciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Alimera Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alimera Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alimera Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Alimera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alimera Sciences's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.